Director to lead Insulin Resistance Department at Novo Nordisk Research Centre Oxford
Novo Nordisk is looking for a highly skilled and people oriented Director to lead a new Department of Insulin Resistance at our Research Centre in Oxford. This Transformational Research Unit (TRU) will focus on early stage research and innovation in the treatment of type 2 diabetes and other cardio metabolic diseases. You will be based at the Novo Nordisk Research Centre Oxford (NNRCO) in the UK, which is a strategic alliance between Oxford University and Novo Nordisk. We invite you to join us in this exciting endeavour and to make it a success.
About Novo Nordisk Research Centre Oxford (NNRCO)
NNRCO is our new translational research institute focused on biology and target discovery related to type 2 diabetes and cardiometabolic diseases. With its close proximity to academic centers of excellence, NNRCO embraces collaborative opportunities in a unique and innovative ecosystem These collaborations aim to advance discovery and translational research, which ultimately will yield innovative therapies that will make a difference to the lives of patients.
In addition, NNRCO scientists are an integral part of the Novo Nordisk Global Drug Discovery (GDD) unit, which specialises in discovery and development of biological medicines for the treatment of Diabetes, Obesity, Cardiovascular & Liver diseases. Cross-country collaborations within the organisation as well as with external partners are part of our working modus. You can read more about Novo Nordisk Research Centre Oxford at: http://www.novonordisk.co.uk/about-novo-nordisk-in-uk/oxford-research-centre.html
The main focus for the new Department of Insulin Resistance will be the discovery, validation and early pipeline progression of innovative first in class insulin resistance and broadly related MOA targets (for example in adipose, muscle and/or liver tissue). NNRCO has a strong emphasis in applying human phenotypic, genetic and multi-omic data to target discovery using human cellular disease models, functional genomics and phenotypic screens. The scope is broad and you will be expected to use creativity and strategic judgement to realize the scientific goals with considerable autonomy. The entire department will be expected to help establish and support a strong and healthy working culture in an agile and creative environment with a positive attitude and ‘can do’ approach. The Department of Insulin Resistance will be a unique hybrid experimental team that places industry and academic scientists in the same labs to improve translational innovation. Further to this NNRCO offers great career development opportunities for employees across the scientific spectrum.
As Director, you will be building and leading a state-of-the-art Department of Insulin Resistance recognised worldwide for its innovative approach to research with specific focus on first-in-class targets that have strong translational evidence. You will hold the day-to-day managerial responsibility of the department’s employees, as well as define and setting the strategic direction for research in Insulin Resistance, aligned with the targets and priorities set by GDD at Novo Nordisk. The position will report into the NNRCO Site Head and be a member of the Site management team.
PhD and/or MD, or equivalent. You must have significant post-doctoral training/experience in a directly relevant field and have established internationally recognized excellence. Experience in pharmaceutical target discovery in human-centric academic science is a prerequisite. Having independently led an academic or industrial research team for several years with a proven track record will be preferential for this position.
- Innovative, open to new ideas and have a forward looking strategic mindset
- A strong communicator with solid presentation and English skills
- A strong internal and external networker
- Flexible and adaptable to change, striving in a highly dynamic and challenging environment
As a leader, you develop your team and set high standards for behaviour and performance across. As an individual, you thrive in a dynamic and challenging translational research environment where there is attention to high quality and room for innovation, impacting the strategic direction and setting ambitious goals.
Working at Novo Nordisk
At Novo Nordisk, your skills, dedication and ambition help us change lives for diabetes patients to the better. In exchange, we offer you an opportunity to work with extraordinary talents and you will benefit from a range of possibilities for professional and personal development.
Millions rely on us
To work for Novo Nordisk you will need the skills, dedication and ambition to change lives for the better for millions of patients living with diabetes and other chronical diseases. In exchange, we offer the chance to be part of a truly global workplace, where passion and engagement are met with opportunities for professional and personal development.